(Reuters) - WCG Clinical Inc, a clinical trial solutions company backed by Singapore’s sovereign wealth fund GIC, on Wednesday filed to withdraw its initial public offering in the United States. Reporting by Niket Nishant in Bengaluru; Editing by Shailesh Kuber Our Standards: The Thomson Reuters Trust Principles.
مشاركة :